Search Results 931-940 of 16357 for monoclonal antibody

1. Ph 3 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients with Relapsed or Refractory ALL - Mayo Clinic

   Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic ...

2. An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum - Mayo Clinic

   Participation eligibility · Clinical evidence of acutely infected pyoderma gangrenosum · History of allergic or anaphylactic reactions to monoclonal antibodies ...

3. Study in Pediatrics with HypEREosinophilic Syndrome - Mayo Clinic

   Participants who have received any other monoclonal antibodies ... Participants with any history of hypersensitivity to any monoclonal antibody (including ...

4. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

   History of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies. ... antibody-forming cells and of T cells into effector ...

5. Publications - Div Dubey, M.B.B.S. - Mayo Clinic

   ... antibody positivity. Epilepsia. 2024 Oct; 65 (10):e182 ... Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.

6. Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease - Mayo Clinic News Network

   Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease. 00:00. |. Herd immunity, antibodies & COVID-19 / bile duct cancer / ...

7. Overview - Department of Immunology - Mayo Clinic Research

   Chronic inflammation; Infections; Tissue transplantation. Two institutional core research resources, the Antibody Hybridoma Core and the Immune Monitoring Core, ...

8. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

   ≥ 200 mg/24 hours of monoclonal protein on a 24-hour urine protein electrophoresis. ... Monoclonal bone marrow plasmacytosis ≥ 30% (evaluable disease).

9. Publications - Nipunie S. Rajapakse, M.D., M.P.H. - Mayo Clinic

   Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents. J Pediatric Infect Dis Soc ...

10. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... antibody Patients in Expansion Phase, Cohorts 2 and 3; Previously ... Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to baseline ...